- Nanalysis Announces First Quarter 2024 Conference Call
- Nanalysis Announces Fourth Quarter and Full Year 2023 Results
- /C O R R E C T I O N -- Nanalysis Scientific Corp./
- Nanalysis Announces Full Year 2023 Conference Call
- Nanalysis Scientific Corp. Announces Director Resignation
- Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
- NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT
- Canadian Investment Regulatory Organization Trading Halt - NSCI
- NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT
More ▼
Key statistics
As of last trade, Nanalysis Scientific Corp (NSCI:CVE) traded at 0.45, 30.43% above the 52 week low of 0.345 set on Mar 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.45 |
---|---|
High | 0.45 |
Low | 0.45 |
Bid | 0.445 |
Offer | 0.475 |
Previous close | 0.44 |
Average volume | 42.16k |
---|---|
Shares outstanding | 111.72m |
Free float | 104.51m |
P/E (TTM) | -- |
Market cap | 49.29m CAD |
EPS (TTM) | -0.1608 CAD |
Data delayed at least 15 minutes, as of May 24 2024 14:30 BST.
More ▼